Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Entospletinib

🥰Excellent
Catalog No. T6101Cas No. 1229208-44-9
Alias GS-9973

Entospletinib (GS-9973) (IC50= 7.7 nM)is a specific Syk inhibitor, which is orally bioavailable.

Entospletinib

Entospletinib

🥰Excellent
Purity: 99.51%
Catalog No. T6101Alias GS-9973Cas No. 1229208-44-9
Entospletinib (GS-9973) (IC50= 7.7 nM)is a specific Syk inhibitor, which is orally bioavailable.
Pack SizePriceAvailabilityQuantity
1 mg$32In Stock
2 mg$45In Stock
5 mg$74In Stock
10 mg$98In Stock
25 mg$178In Stock
50 mg$272In Stock
100 mg$438In Stock
200 mg$649In Stock
1 mL x 10 mM (in DMSO)$81In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Entospletinib"

Select Batch
Purity:99.51%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Entospletinib (GS-9973) (IC50= 7.7 nM)is a specific Syk inhibitor, which is orally bioavailable.
Targets&IC50
Syk:IC50: 7.7 nM
In vitro
In cells, GS-9973 also displays excellent specificity for Syk, and effectively inhibits BCR-mediated activation and proliferation of B-cells, as well as immune-complex-stimulated cytokine production in monocytes. In Caco-2 cell, GS-9973 exhibits good bidirectional permeability across cell monolayers.
In vivo
In rat and dog, Entospletinib (1 mg/kg) by oral administration shows moderate to high bioavailability. In a rat collagen-induced arthritis model, Entospletinib (1-10 mg/kg) by oral administrations significantly suppress ankle inflammation. Entospletinib(ED50 =1.2 -3.9 mg/kg) exhibits disease-modifying activity such as pannus formation, cartilage damage, bone resorption, and periosteal bone formation.
Kinase Assay
In the determination of full-length baculovirus expressed Syk kinase activity, the reaction system was 25 μL containing 25 mM Tris-HCl, pH 7.5, 5 mM β-glycerophosphate, 2 mM DTT, 0.1 mM Na3VO4, 10 mM MgCl2, 0.5 μM Promega PTK Biotin Peptide Substrate 1, 0.01% casein, 1, 0.01% Triton X-100, 0.25% Glycerol, and 40 mM ATP (Km for ATP). After incubation for 60 minutes at room temperature, the reaction was stopped by adding 30 mM EDTA (30 μL of SA-APC and 4 nM PT-66 antibody). After measuring the plate, the IC50 value of the test compound was calculated using a 4-parameter linear regression algorithm.
Cell Research
In MV-4-11 cells, the functional effect of the compound on the cellular Flt3 activity was determined by inhibition of cell proliferation. Cells were diluted in 96 well flat bottom tissue culture plates in RPMI medium containing 10% FBS and compound dilutions were added and incubated at 37°C for 72 hours. Aramazol (10%) was added to the cells and the cells were incubated for another 12-18 hours at 37°C. Finally, the inhibition of the relative cell number was measured at 570/600 nm in the spectrophotometer.
Animal Research
In the rat collagen-induced arthritis (CIA) model, Entospletinib (10 mg/kg), which is dissolved in hydrogenated castor oil,ethanol or physiological saline, is taken by oral.
AliasGS-9973
Chemical Properties
Molecular Weight411.46
FormulaC23H21N7O
Cas No.1229208-44-9
SmilesC1CN(CCO1)c1ccc(Nc2nc(cn3ccnc23)-c2ccc3cn[nH]c3c2)cc1
Relative Density.1.45 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 50 mg/mL (121.52 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.4304 mL12.1518 mL24.3037 mL121.5185 mL
5 mM0.4861 mL2.4304 mL4.8607 mL24.3037 mL
10 mM0.2430 mL1.2152 mL2.4304 mL12.1518 mL
20 mM0.1215 mL0.6076 mL1.2152 mL6.0759 mL
50 mM0.0486 mL0.2430 mL0.4861 mL2.4304 mL
100 mM0.0243 mL0.1215 mL0.2430 mL1.2152 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Entospletinib | purchase Entospletinib | Entospletinib cost | order Entospletinib | Entospletinib chemical structure | Entospletinib in vivo | Entospletinib in vitro | Entospletinib formula | Entospletinib molecular weight